The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot ExperienceKai Ninomiya, Yoshinobu Onuma, Scot Garg et al.|Reviews in Cardiovascular Medicine|2022Cited by 5